|Day Low/High||23.55 / 24.34|
|52 Wk Low/High||17.92 / 73.23|
Grant awards in 2016 support promising research aimed at improving the health of mothers and babies
In trading on Thursday, shares of AMAG Pharmaceuticals, Inc. crossed below their 200 day moving average of $23.98, changing hands as low as $23.80 per share.
In trading on Friday, shares of AMAG Pharmaceuticals, Inc. crossed below their 200 day moving average of $24.16, changing hands as low as $23.74 per share.
Investors considering a purchase of AMAG Pharmaceuticals, Inc. stock, but tentative about paying the going market price of $24.29/share, might benefit from considering selling puts among the alternative strategies at their disposal.
In trading on Thursday, shares of AMAG Pharmaceuticals, Inc. crossed above their 200 day moving average of $24.42, changing hands as high as $24.60 per share.
Trade-Ideas LLC identified AMAG Pharmaceuticals (AMAG) as a "perilous reversal" (up big yesterday but down big today) candidate
Investors in AMAG Pharmaceuticals, Inc. saw new options begin trading this week, for the February 2017 expiration.
The daily chart flashes hope as bulls push out of a bullish flag.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.